A carregar...
Recent advances in the management of osteoporosis
There has been substantial progress in the management of patients with osteoporosis and the prevention of osteoporotic fractures. Currently available strong anti-resorptive agents are bisphosphonates and an anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody, denosumab. Althoug...
Na minha lista:
| Publicado no: | F1000Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
F1000Research
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5428497/ https://ncbi.nlm.nih.gov/pubmed/28529724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.10682.1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|